Computational Drug Discovery Market, Global Outlook and Forecast 2023-2035
Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
This report aims to provide a comprehensive presentation of the global market for Computational Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Drug Discovery. This report contains market size and forecasts of Computational Drug Discovery in global, including the following market information:
Global Computational Drug Discovery Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Computational Drug Discovery market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Structure-based Drug Design (SBDD) Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Computational Drug Discovery include AMRI, Charles River, Schr?dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Computational Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Drug Discovery Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Computational Drug Discovery Market Segment Percentages, by Type, 2022 (%)
Structure-based Drug Design (SBDD)
Ligand-based Drug Design (LBDD)
Sequence-based Approaches
Global Computational Drug Discovery Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Computational Drug Discovery Market Segment Percentages, by Application, 2022 (%)
Oncological Disorders
Neurological Disorders
Immunological Disorders
Infectious Diseases
Others
Global Computational Drug Discovery Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Computational Drug Discovery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Computational Drug Discovery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Computational Drug Discovery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AMRI
Charles River
Schr?dinger
Evotec
Bayers
GVK Biosciences
AstraZeneca
BioDuro
BOC Sciences
Aris Pharmaceuticals
ChemDiv
RTI International
XRQTC
Pharmaron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Computational Drug Discovery, market overview.
Chapter 2: Global Computational Drug Discovery market size in revenue.
Chapter 3: Detailed analysis of Computational Drug Discovery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Computational Drug Discovery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
